Thrombolytic Science

Thrombolytic Science is a privately-held biotechnology company developing a new generation of clot-busting therapies for heart attacks, ischemic strokes, and other thrombotic diseases based on the groundbreaking research of its scientific co-founders at BIDMC/Harvard Medical School on prourokinase.